Monday, May 09, 2011 6:26:49 PM
The disconnect I have is who's tending to the practical side of KBLB's business development so they might take advantage of those limitless opportunities? I Kim taking the point in KBLB's day-in day-out drudge and trudge required for a company to take advantage of supplying markets with product(s) demanded by them?
You do bring up an interesting question in your attempt to understand what form KBLB's business might take when you say..
"KBLB's business model could be: Genetically modify an organism (first in the silkworm using its spider genes) to produce a product, make a deal for royalties with some company(or companies) to produce that product and after that the royalties continue to come in with negligible further input or effort from KBLB. Take the money and on the next one, expand the company to enable working on multiple projects simultaneously."
I think the majority of the board here believes KBLB's business is simply to "make spider silk and then sell it for a profit". I don't know myself, as I've seen no guidance from management beyond "we are a research and development company involved in the genetic modification of silk worms which is in transition and plans are to leverage these results of our GM Silkworm into commercial applications requiring the use of our spider-silk products" (me paraphrasing).
Does anyone here know the physical make-up of the board well enough to know they can and will make the proper hires to walk this company forward regardless?
This is what I am looking for here and I hope to see it. Any comments along these lines will be appreciated by me in particular. If is see something along these lines of import I'll surely be passing it on to the board.
Thanks for your insights.
RU
Recent KBLB News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 10:14:03 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/19/2024 09:30:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/19/2024 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 11/05/2024 12:00:04 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
UAV Corp. Revolutionizes Surveillance with AI-Powered Skyborne enhanced WAMI Technology • UMAV • Jan 28, 2025 1:30 PM
Should Bitcoin be added to the Dollar Index? Does Irrational Exuberance prelude a Bubble? Do Investors love Crypto or just the money? • BEGI • Jan 28, 2025 11:00 AM
Unitronix Corp. to File Patent to Secure Blockchain Innovation and Increase DeFi Adoption • UTRX • Jan 28, 2025 7:30 AM
LaFleur Minerals Provides Updates on Exploration at Swanson Gold Deposit and Plans to Restart of Beacon Gold Mill • LFLRF • Jan 27, 2025 9:47 AM
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform • AVAI • Jan 27, 2025 8:00 AM
$BEOLF: Will Beyond Oil Skyrocket Monday? Multi-Million Dollar U.S. Deal Backed by Trump Advisor Aiming to Implement them as a US Standard • RKLB • Jan 27, 2025 7:10 AM